Amarin Corporation
AMRN
$0.87
Share price
1.72%
Change (1 day)
-31.11%
Change (1 year)
Categories
Amarin Corporation (AMRN) - P/B ratio
P/B ratio as of April 2024 : 0.6314
According to Amarin Corporation
's latest financial reports the company has a price-to-book ratio of 0.6314.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Amarin Corporation - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.6434 | -21.61% |
| 2022-12-31 | 0.8208 | -58.95% |
| 2021-12-31 | 2.00 | -34.63% |
| 2020-12-31 | 3.06 | -75.9% |
| 2019-12-31 | 12.7 | -56.4% |
| 2018-12-31 | 29.1 | -274.48% |
| 2017-12-31 | -16.7 | -81.82% |
| 2016-12-31 | -91.8 | 3277.73% |
| 2015-12-31 | -2.72 | 40.53% |
| 2014-12-31 | -1.93 | -80.75% |
| 2013-12-31 | -10.0 | -96.7% |
| 2012-12-31 | -304 | 78.34% |
| 2011-12-31 | -171 | 3840.93% |
| 2010-12-31 | -4.33 | -120.22% |
| 2009-12-31 | 21.4 | 4260.42% |
| 2008-12-31 | 0.4911 | -67.2% |
| 2007-12-31 | 1.50 | -72.01% |
| 2006-12-31 | 5.35 | 121.76% |
| 2005-12-31 | 2.41 | -60.52% |
| 2004-12-31 | 6.11 | -240.38% |
| 2003-12-31 | -4.35 | -31.11% |
| 2002-12-31 | -6.32 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 AbbVie ABBV | 27.2 | 4,205.55% | 🇺🇸 USA |
 AstraZeneca AZN | 5.95 | 842.49% | 🇬🇧 UK |
 GlaxoSmithKline GSK | 5.16 | 718.01% | 🇬🇧 UK |
 Alkermes ALKS | 3.47 | 449.55% | 🇮🇪 Ireland |
 Teva Pharmaceutical Industries TEVA | 1.92 | 204.88% | 🇮🇱 Israel |